New York State Common Retirement Fund’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

New York State Common Retirement Fund’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6	Closed	-$1K	–	3562
2021 Q2	$1K	Sell	6 -454	-99%	-$50.1K	﹤0.01%	3501
2021 Q1	$68K	Hold	460	–	–	﹤0.01%	3156
2020 Q4	$64K	Sell	460 -330	-42%	-$53.5K	﹤0.01%	3149
2020 Q3	$120K	Hold	790	–	–	﹤0.01%	2850
2020 Q2	$139K	Buy	+790	New	+$132K	﹤0.01%	2810
2017 Q2	–	Sell	-102	Closed	-$34K	–	3252
2017 Q1	$34K	Hold	102	–	–	﹤0.01%	3092
2016 Q4	$61K	Hold	102	–	–	﹤0.01%	3038
2016 Q3	$116K	Hold	102	–	–	﹤0.01%	2951
2016 Q2	$112K	Hold	102	–	–	﹤0.01%	2950
2016 Q1	$131K	Hold	102	–	–	﹤0.01%	2860
2015 Q4	$251K	Hold	102	–	–	﹤0.01%	2652
2015 Q3	$113K	Sell	102 -21	-17%	-$24.3K	﹤0.01%	2998
2015 Q2	$123K	Buy	123 +21	+21%	+$22.6K	﹤0.01%	3061
2015 Q1	$104K	Buy	+102	New	+$337K	﹤0.01%	2219

Other funds holding NBSE

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

JAMONY

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New York State Common Retirement Fund's NBSE Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q3 2021, closing a stake of 6 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in NBSE in Q1 2015 and held it in 14 quarters. The position peaked at $251K in Q4 2015. 47 funds tracked by Wall St. Rank hold NBSE as of Q3 2021.

New York State Common Retirement Fund reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
New York State Common Retirement Fund sold 6 NeuBase Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $1K.
New York State Common Retirement Fund first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q1 2015 and held it in 14 quarters.
New York State Common Retirement Fund's NeuBase Therapeutics, Inc. Common Stock position peaked at $251K in Q4 2015.
47 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.